Epigenetic reprogramming synergizes with PD-1/PD-L1 inhibition for cell-targeted therapy in hepatocellular carcinoma

被引：0
|
作者：
Sukowati, Caecilia [1 ,2 ,3 ]
Cabral, Loraine Kay [3 ,4 ]
Anfuso, Beatrice [5 ]
Tiribelli, Claudio [3 ]
机构：
[1] Natl Res & Innovat Agcy Indonesia, Jakarta, Indonesia
[2] Eijkman Res Ctr Mol Biol, Jakarta, Indonesia
[3] Fdn Italiana Fegato ONLUS, Basovizza, Italy
[4] Univ Trieste, Doctoral Sch Mol Biomed, Trieste, Italy
[5] Univ Trieste, Dept Life Sci, Trieste, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-273
引用
收藏
页码：S559 / S559
页数：1
相关论文
共 50 条
  • [41] Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
    Zhang, Nan
    Yang, Xu
    Piao, Mingjian
    Xun, Ziyu
    Wang, Yunchao
    Ning, Cong
    Zhang, Xinmu
    Zhang, Longhao
    Wang, Yanyu
    Wang, Shanshan
    Chao, Jiashuo
    Lu, Zhenhui
    Yang, Xiaobo
    Wang, Hanping
    Zhao, Haitao
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [42] PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?
    Erlmeier, Franziska
    Hartmann, Arndt
    Autenrieth, Michael
    Wiedemann, Max
    Ivanyi, Philipp
    Steffens, Sandra
    Weichert, Wilko
    MEDICAL ONCOLOGY, 2016, 33 (11)
  • [43] Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines
    Pinard, Christopher J.
    Hocker, Samuel E.
    Poon, Andrew C.
    Inkol, Jordon M.
    Matsuyama, Arata
    Wood, R. Darren
    Wood, Geoffrey A.
    Woods, J. Paul
    Mutsaers, Anthony J.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2022, 243
  • [44] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    MODERN PATHOLOGY, 2015, 28 : 123A - 123A
  • [45] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
  • [46] PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
    Mitteldorf, Christina
    Berisha, Arbeneshe
    Tronnier, Michael
    Pfaltz, Monique C.
    Kempf, Werner
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (09) : 740 - 746
  • [47] PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?
    Franziska Erlmeier
    Arndt Hartmann
    Michael Autenrieth
    Max Wiedemann
    Philipp Ivanyi
    Sandra Steffens
    Wilko Weichert
    Medical Oncology, 2016, 33
  • [48] The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck
    Zandberg, Dan P.
    Strome, Scott E.
    ORAL ONCOLOGY, 2014, 50 (07) : 627 - 632
  • [49] PD-L1 copy number gains: a predictive biomarker for PD-1/PD-L1 blockade therapy?
    Inoue, Yusuke
    Osman, Murat
    Suda, Takafumi
    Sugimura, Haruhiko
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S199 - S202
  • [50] Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition
    Sodji, Quaovi
    Klein, Kandy
    Sravan, Kavuri
    Parikh, Jigarkumar
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345